Skip to main content
Clinical Trials/IRCT20211118053097N1
IRCT20211118053097N1
Not yet recruiting
未知

Evaluation of the efficacy of memantine in improvement of behavioral disorders and electroencephalographic findings in children with autistic spectrum disorder aged 4-12 years old

Shiraz University of Medical Sciences0 sites52 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
52
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with ASD according to DSM 5
  • Patients with no previous history of epilepsy and/or abnormal electroencephalography
  • Patients aged between 4 to 12 years old

Exclusion Criteria

  • Intolerance to Memantine
  • Patients and/or their caregiver’s disinclination to continuing with trail

Outcomes

Primary Outcomes

Not specified

Similar Trials